---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-241059"
form_type: "8-K"
ticker: "ARTV"
cik: "0001817241"
company_name: "Artiva Biotherapeutics, Inc."
filed_at: "2024-10-22T23:59:59+00:00"
generated_at: "2026-05-30T11:45:45.025733+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Artiva appoints Alison Moore Ph.D. as Class III director and committee member

## Summary
- Alison Moore appointed as Class III director with term expiring at 2027 annual meeting; also joins Technical Operations Committee.
- Dr. Moore is Chief Technical Officer at Codexis (since Oct 2024); previously CTO/EVP at Allogene Therapeutics and SVP at Amgen.
- Receives annual cash retainer of $40,000 for board service and $15,000 for Technical Operations Committee service.
- Granted option to purchase 27,500 shares, one-third vested immediately, remainder vesting monthly over two years.
- Will receive automatic annual option grants of 13,750 shares at each annual meeting, vesting over one year.

## SEC filing metadata
- accession: 0001193125-24-241059
- form_type: 8-K
- ticker: ARTV
- cik: 0001817241
- company_name: Artiva Biotherapeutics, Inc.
- filed_at: 2024-10-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1817241/000119312524241059/0001193125-24-241059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1817241/000119312524241059/d855080d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-241059
- JSON: https://secwatch.observer/filing/0001193125-24-241059.json
- Plain text: https://secwatch.observer/filing/0001193125-24-241059.txt

## Key facts
- Executive change
  Alison Moore was appointed as Class III Director at Artiva Biotherapeutics, Inc..
  - Action: appointed
  - Role: Class III Director
  source text: appointed Alison Moore, Ph.D. as (i) a Class III director of the Company, with a term of office expiring at the 2027 annual meeting of stockholders and (ii) a member of the Technical Operations Committee of the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1817241/000119312524241059/0001193125-24-241059-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.